raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:614

Thomsen and Becker disease

Synonyms: Myotonia congenita

Type
Disease
Group
Disorder
Inheritance
Autosomal dominant, Autosomal recessive
Age of onset
Adolescent, Adult, Childhood, Infancy
Status
active

A rare, genetic, skeletal muscle channelopathy characterized by slow muscle relaxation after contraction (myotonia).

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enThomsen and Becker diseaseMyotonia congenita
frMyotonie congénitale de Thomsen et Becker
deMyotonia congenita Typ Thomsen und Becker= en
esEnfermedad de Thomsen y Becker
itMalattia di Thomsen e Becker
nlZiekte van Thomsen en Becker= en
ptDoença de Thomsen e BeckerMiotonia congénita
plChoroba Thomsena i BeckeraMiotonia wrodzona
csThomsenova a Beckerova chorobaKongenitální myotonie · Thomsenova a Beckerova nemoc · Thomsenova vrozená myotonie
ukХвороба Томсена і БеккераВроджена міотонія
zh先天性肌强直先天性肌强直
trThomsen ve Becker hastalığıMiyotoni konjenita

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM160800BTNTvalidated
OMIM255700BTNTvalidated
ICD-10G71.1NTBTinclusionvalidated
ICD-118C71.2Especificvalidated
MONDO0009710Evalidated
UMLSC0027127Evalidated
GARD12301Evalidated
MedDRA10028655Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (2):

No children.

Codes that Orphanet moved or referred to this one:

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
CLCN1Disease-causing germline mutation(s) (loss of function) inAssessedHGNC:2019ENSG000001880371184257q34chloride voltage-gated channel 120301529[PMID]
5

Prevalence and incidence

6 records
TypeClassValueAreaQualificationValidationSource
Point prevalence1-9 / 100 0001 / 100 000WorldwideValue and classValidated1822774[PMID]
Point prevalence1-9 / 100 000—EuropeClass onlyValidatedORPHANET
Point prevalence1-9 / 100 0007.3 / 100 000FinlandValue and classValidated9598722[PMID]
Point prevalence1-9 / 1 000 0000.9 / 100 000ItalyValue and classValidated7161034[PMID]
Point prevalence1-9 / 1 000 0000.75 / 100 000NetherlandsValue and classValidated29606556[PMID]
Point prevalence1-9 / 1 000 0000.52 / 100 000United KingdomValue and classValidated23516313[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

15 annotations · validated 2024-03-28
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0003457EMG abnormality
HP:0100284EMG: myotonic discharges
HP:0003552Muscle stiffness
HP:0002486Myotonia
HP:0003740Myotonia with warm-up phenomenon
Frequent (79-30%)
HP:0003326Myalgia
HP:0003712Skeletal muscle hypertrophy
Occasional (29-5%)
HP:0002312Clumsiness
HP:0003458EMG: myopathic abnormalities
HP:0008872Feeding difficulties in infancy
HP:0003394Muscle spasm
HP:0009063Progressive distal muscle weakness
Very rare (<4-1%)
HP:0011675Arrhythmia
HP:0031546Cardiac conduction abnormality
HP:0002015Dysphagia

Run the differential on the 5 obligate / very frequent terms

Annotation source: 32966006[PMID]_20301529[PMID]_35170402[PMID]

7

Sources for this card